Should You Avoid Bio-Reference Laboratories Inc (BRLI)?
At the moment, there are dozens of gauges market participants can use to analyze the equity markets. A duo of the most under-the-radar are hedge fund and insider trading movement.
Trius Therapeutics Inc (TSRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Amici Capital Paul Orlin And Alex Porter | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.80 | 2,000 | Director | 13,270 | 2011-08-29 | Filing | |
| $6.48 | 133 | Officer | 133 | 2011-08-22 | Filing | |
| $3.50 | 1,000 | Director | 11,270 | 2010-11-23 | Filing | |
| $5.00 | 830,000 | Large Shareholder | 3,615,572 | 2010-08-06 | Filing | |
| $5.00 | 914,529 | Large Shareholder, Director | 3,235,839 | 2010-08-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.10 | 1,000 | Officer | 166,860 | 2013-07-22 | Filing | |
| $10.55 | 3,500 | Officer | 167,860 | 2013-07-15 | Filing | |
| $10.10 | 5,000 | Officer | 171,360 | 2013-07-12 | Filing | |
| $9.32 | 500 | Officer | 176,360 | 2013-07-11 | Filing | |
| $8.58 | 1,000 | Officer | 176,860 | 2013-07-10 | Filing |
Institutional Investors' Holdings
News See All
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): The 10 Most Common Reasons People Visit Their Doctor
With the full implementation of the individual portion of the Patient Protection and Affordable Care Act less than five months away, physicians and doctor's offices around the country should be bracing...
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): How Could This Deal Shake Up an Entire Industry?
With two simultaneous moves that have set the pharmaceutical world on fire, Cubist Pharmaceuticals Inc (NASDAQ:CBST) has triumphantly announced its arrival on the global stage.
Cubist Pharmaceuticals Inc (CBST), Trius Therapeutics, Inc. (TSRX): This Week in Biotech
With the SPDR S&P Biotech Index up 43% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Cubist Pharmaceuticals Inc (CBST), Optimer Pharmaceuticals, Inc. (OPTR), Trius Therapeutics, Inc. (TSRX): Will This Biotech Company’s Big Bet Pay Off?
Cubist Pharmaceuticals Inc (NASDAQ:CBST) surged 10% on July 31, after the company acquired two antibiotic makers, Optimer Pharmaceuticals, Inc. (NASDAQ:OPTR) and Trius Therapeutics, Inc.
Is Novadaq Technologies Inc. (NVDQ) Going to Burn These Hedge Funds?
In the financial world, there are a multitude of gauges market participants can use to track their holdings. A couple of the best are hedge fund and insider trading sentiment.
Nordion Inc (USA) (NDZ): Insiders Aren't Crazy About It
To most traders, hedge funds are viewed as worthless, old financial tools of the past.
Trius Therapeutics, Inc. (TSRX): Are Hedge Funds Right About This Stock?
Trius Therapeutics, Inc. (NASDAQ:TSRX) was in 8 hedge funds' portfolio at the end of December. TSRX has experienced a decrease in enthusiasm from smart money recently.
China Cord Blood Corp (NYSE:CO), Trius Therapeutics, Inc. (NASDAQ:TSRX): Hedge Funds Are Dumping Nordion Inc (USA) (NYSE:NDZ)
According to most stock holders, hedge funds are seen as slow, outdated investment tools of the past.
Biogen Idec Inc. (BIIB), United Therapeutics Corporation (UTHR), Repros Therapeutics Inc (RPRX): This Week in Biotech
With the SPDR S&P Biotech (ETF) (NYSEARCA:XBI) Index up 25% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Billionaire Hedge Funds
